Clinical Trial Recruitment Lab

The Clinical Trial Recruitment Lab (CTRL) pilots, evaluates, and disseminates innovative recruitment strategies to improve access and representation in clinical trials. CTRL’s goal is to coordinate the resources and expertise needed to design and conduct pilots that test real-world solutions, generate evidence, and share best practices to improve recruitment at scale. CTRL brings together stakeholders from academia, industry, and philanthropy to create a collaborative platform for testing innovative strategies in real-world settings.

Program Leadership

**Paul Aisen, MD**
Director, Alzheimer’s Therapeutic Research Institute

**Phyllis Ferrell, DrPH, MBA**
Nonresident Scholar, USC Schaeffer Institute

**Dana Goldman, PHd**
Founding Director, USC Schaeffer Institute

**Mireille Jacobson, PhD**
Co-Director, Aging and Cognition Program, USC Schaeffer Center

**Desi Peneva, MS**
Research Program Lead, USC Schaeffer Center

**Rema Raman, PhD**
Director, Alzheimer’s Trial Recruitment Innovation Lab

CTRL News and Research View All

How a Gift Card Could Help Speed Up Alzheimer’s Clinical Research

Offering a small gift card boosted enrollment in a patient registry, though other approaches for engaging low-income patients may be more cost-effective.

Aging

Experts: Mireille Jacobson, Doris Molina-Henry

Alzheimer’s Breakthroughs Are on the Horizon — If We Can Get Patients Into Trials

Advancing the Science of Recruitment for Alzheimer’s Clinical Trials: Challenges and Opportunities

Clinical Trial Knowledge Hub

Stronger, more efficient clinical trial recruitment can help accelerate the search for new Alzheimer’s treatments. The Knowledge Hub brings together evidence from our innovative pilots, best practices from the field and insights from leading researchers.

Learn More

Featured White Paper

Key Barriers for Clinical Trials for Alzheimer’s Disease

Alzheimer’s disease (AD) clinical trials are more complicated, costly, and slower than trials for other diseases. Addressing barriers would accelerate the approval of innovative therapies.

Experts: Dana Goldman, Niranjan Bose

Read: Key Barriers for Clinical Trials for Alzheimer’s Disease

Ongoing Studies

The Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) seeks to diversify participant recruitment and accelerate the process of enrolling a representative population in preclinical and prodromal Alzheimer’s clinical trials through evidence-based science, community engagement and training.

Alzheimer’s Trial Recruitment Innovation Lab

More Clinical Trial Research View All

Testimony

Testimony on Accelerating Medical Breakthroughs for American Patients and Their Families

Rational and forward-thinking regulatory reforms can stimulate and enable the uptake of new medical technologies that make good health more accessible and affordable.

Featured Experts: Darius Lakdawalla

Testimony

Testimony on Maintaining U.S. Biotech Competitiveness and Delivering Lifesaving Cures to Patients

News

Former FDA Leaders Say New Policies Needed to Boost Medical Innovation

News

Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access

In The News View All

Axios